In:
Proceedings of the National Academy of Sciences, Proceedings of the National Academy of Sciences, Vol. 96, No. 6 ( 1999-03-16), p. 3053-3058
Abstract:
Proteolytic processing of the amyloid precursor protein by β-secretase yields A4CT (C99), which is cleaved further by the as yet unknown γ-secretase, yielding the β-amyloid (Aβ) peptide with 40 (Aβ 40 ) or 42 residues (Aβ 42 ). Because the position of γ-secretase cleavage is crucial for the pathogenesis of Alzheimer’s disease, we individually replaced all membrane-domain residues of A4CT outside the Aβ domain with phenylalanine, stably transfected the constructs in COS7 cells, and determined the effect of these mutations on the cleavage specificity of γ-secretase (Aβ 42 /Aβ 40 ratio). Compared with wild-type A4CT, mutations at Val-44, Ile-47, and Val-50 led to decreased Aβ 42 /Aβ 40 ratios, whereas mutations at Thr-43, Ile-45, Val-46, Leu-49, and Met-51 led to increased Aβ 42 /Aβ 40 ratios. A massive effect was observed for I45F (34-fold increase) making this construct important for the generation of animal models for Alzheimer’s disease. Unlike the other mutations, A4CT-V44F was processed mainly to Aβ 38 , as determined by mass spectrometry. Our data provide a detailed model for the active site of γ-secretase: γ-secretase interacts with A4CT by binding to one side of the α-helical transmembrane domain of A4CT. Mutations in the transmembrane domain of A4CT interfere with the interaction between γ-secretase and A4CT and, thus, alter the cleavage specificity of γ-secretase.
Type of Medium:
Online Resource
ISSN:
0027-8424
,
1091-6490
DOI:
10.1073/pnas.96.6.3053
Language:
English
Publisher:
Proceedings of the National Academy of Sciences
Publication Date:
1999
detail.hit.zdb_id:
209104-5
detail.hit.zdb_id:
1461794-8
SSG:
11
SSG:
12
Permalink